Her main research concerns Molecular biology, In vivo, Antibody, Antigen and Carcinoembryonic antigen. Her Molecular biology study incorporates themes from In vitro, Naked DNA, Receptor, Reporter gene and Gene. Many of her research projects under In vivo are closely connected to Linker with Linker, tying the diverse disciplines of science together.
While the research belongs to areas of Antibody, Anna M. Wu spends her time largely on the problem of Molecular imaging, intersecting her research to questions surrounding Positron emission tomography, Magnetic resonance imaging, Disease, Medical imaging and Internal medicine. Her Carcinoembryonic antigen research integrates issues from Pharmacokinetics and Transplantation. Anna M. Wu studied Quantum dot and Cellular imaging that intersect with Nanotechnology.
Anna M. Wu focuses on Antibody, Molecular biology, In vivo, Cancer research and Biodistribution. Her studies deal with areas such as Carcinoembryonic antigen, Antigen and Pathology as well as Antibody. Her Molecular biology study which covers Gene that intersects with DNA.
Her study in the field of Molecular imaging and Preclinical imaging is also linked to topics like Linker. Her research in Cancer research focuses on subjects like Prostate cancer, which are connected to Prostate. Her work carried out in the field of Biodistribution brings together such families of science as Nuclear medicine, Ex vivo, Pharmacokinetics and Imaging agent.
Anna M. Wu mainly investigates Cancer research, Biodistribution, Prostate cancer, In vivo and Immunotherapy. Her study in Cancer research is interdisciplinary in nature, drawing from both Cancer, Antigen, Stem cell and Antibody, Monoclonal antibody. Her Antibody study combines topics in areas such as Positron emission tomography, Internalization and Molecular biology.
Her Biodistribution research is multidisciplinary, relying on both Ex vivo, Pharmacokinetics, Radioimmunotherapy, Nuclear medicine and Molecular imaging. Her B16 melanoma study, which is part of a larger body of work in In vivo, is frequently linked to Short exposure, bridging the gap between disciplines. Her Prostate Stem Cell Antigen research incorporates elements of Preclinical imaging and Pancreatic cancer.
Cancer research, Biodistribution, Immunotherapy, Pathology and Prostate cancer are her primary areas of study. She combines subjects such as Antigen, Molecular imaging, In vivo, Stem cell and Antibody with her study of Cancer research. While working on this project, Anna M. Wu studies both In vivo and Short exposure.
As part of one scientific family, she deals mainly with the area of Biodistribution, narrowing it down to issues related to the Pharmacokinetics, and often Lesion. Her study in Immunotherapy is interdisciplinary in nature, drawing from both Positron emission tomography, Cytotoxic T cell and CD8. As a part of the same scientific study, she usually deals with the Pathology, concentrating on Flow cytometry and frequently concerns with Immunohistochemistry, Monoclonal, Prostatectomy, Preclinical imaging and Image-guided surgery.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics
X. Michalet;F. F. Pinaud;L. A. Bentolila;J. M. Tsay.
Arming antibodies: prospects and challenges for immunoconjugates
Anna M Wu;Peter D Senter.
Nature Biotechnology (2005)
Expression of recombinant antibodies in mammalian cell lines.
Paul J. Yazaki;Anna M. Wu.
Methods of Molecular Biology (2004)
Minibody: A Novel Engineered Anti-Carcinoembryonic Antigen Antibody Fragment (Single-Chain Fv-CH3) Which Exhibits Rapid, High-Level Targeting of Xenografts
Shi-zhen Hu;Louise Shively;Andrew Raubitschek;Mark Sherman.
Cancer Research (1996)
Particle Size, Surface Coating, and PEGylation Influence the Biodistribution of Quantum Dots in Living Mice
Meike L. Schipper;Gopal Iyer;Ai Leen Koh;Zhen Cheng.
Effect of fixation on the amplification of nucleic acids from paraffin-embedded material by the polymerase chain reaction.
Jonathan Ben-Ezra;David A. Johnson;John Rossi;Nathan Cook.
Journal of Histochemistry and Cytochemistry (1991)
Consensus guided mutagenesis of Renilla luciferase yields enhanced stability and light output.
Andreas Markus Loening;Timothy David Fenn;Anna M. Wu;Sanjiv Sam Gambhir;Sanjiv Sam Gambhir.
Protein Engineering Design & Selection (2006)
The complete nucleotide sequence of the tryptophan operon of Escherichia coli
C. Yanofsky;T. Platt;I.P. Crawford;B.P. Nichols.
Nucleic Acids Research (1981)
Cd20-specific redirected t cells and their use in cellular immunotherapy of cd20+ malignancies
Andrew Raubitschek;Michael C Jensen;Anna M Wu.
Red-shifted Renilla reniformis luciferase variants for imaging in living subjects
Andreas Markus Loening;Anna M Wu;Sanjiv Sam Gambhir;Sanjiv Sam Gambhir.
Nature Methods (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: